Neonatal alloimmune neutropenia associated with maternal anti-HLA antibodies: a conservative interpretation of a rare presentation

View at publisher Summarise with VIRAT
Authors: Carlos González Pérez, Ana Vidal Esteban, Amanda Bermejo, Isaura Margarita Apostolidis de Oliveira
Cited by: 0
References: 20

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Neonatal alloimmune neutropenia (ANN) is a rare cause of neutropenia in newborns, resulting from maternal antibodies directed against paternal antigens present on fetal neutrophils, in a mechanism similar to Rh haemolytic disease.We present the case of a full-term newborn with severe neutropenia from birth (nadir 110/µL) but no clinical signs of infection. As neutropenia persisted beyond the neonatal period, an immunological study was performed, identifying maternal IgG anti-human leukocyte antigen (HLA) class I and II antibodies and positive cross-match tests against paternal and neonatal neutrophils. While these findings suggest anti-HLA antibodies likely contributed to the neutropenia, the absence of glycoprotein-specific confirmatory assays-such as MAIGA (monoclonal antibody immobilisation of granulocyte antigens) or immunoprecipitation-prevents definitive causal attribution.The outcome was favorable with no need for treatment. Neutropenia resolved spontaneously at 22 weeks of life.Current literature on this entity is reviewed, highlighting its transient nature and good prognosis in most cases.

Fields of Study & Subjects

Blood disorders and treatments Blood groups and transfusion Immunodeficiency and Autoimmune Disorders

Publication details

Journal / source
BMJ Case Reports
Volume
19
Issue
3
Pages
e268797–e268797
Publication date
1 March 2026
Language
EN